Investment
Features
FeesSafety
Academy
More
Pluang+

New studies show sotagliflozin improves heart function and reduces clot risks in cardiovascular disease.

Market News
21 Oct 2026
GlobeNewsWire
View Source
Bullish
New studies show sotagliflozin improves heart function and reduces clot risks in cardiovascular disease.

Lexicon Pharmaceuticals announced two new preclinical studies highlighting sotagliflozin's benefits in cardiovascular disease. The first study showed sotagliflozin improved heart structure and function in hypertrophic cardiomyopathy by reducing oxidative stress and reversing cardiac hypertrophy. The second study found sotagliflozin reduced platelet activation and thrombus formation, unlike selective SGLT2 inhibitors, indicating unique dual SGLT1/2 inhibition effects. These findings support ongoing Phase 3 trials for hypertrophic cardiomyopathy, with results expected in early 2027, potentially expanding treatment options for heart disease patients.

Lexicon Pharmaceuticals' new research on sotagliflozin in cardiovascular disease provides context for health sector performance. For readers following health stocks, 65 of 150 priced US health-sector stocks rose while 76 fell. Notable movers include Twist Bioscience Corp at USD 136.50 with a -4.34% change and 100% buy orders, Abbott Laboratories at USD 98.50 with a -4.09% change and 67% buy orders, and Danaher Corporation at USD 215.50 with a -3.80% change and 79% sell orders. Data is as of Oct 21, 2026 18:42 WIB.

More News

Royal Caribbean updates gratuity disclosures to clarify optional pre-payment, avoiding consumer confusion.

Royal Caribbean updates gratuity disclosures to clarify optional pre-payment, avoiding consumer confusion.

The BBB National Programs’ National Advertising Division reviewed Royal Caribbean Group's advertising related to gratuities and found the company's recent modifications to be supported. Royal Caribbean clarified in its booking process that gratuities...

Market News
Neutral
14 minutes ago
Deutsche Bank raises Kroger price target to $70 on growth plans and new stores.

Deutsche Bank raises Kroger price target to $70 on growth plans and new stores.

Deutsche Bank increased its price target for Kroger to $70 from $68, reflecting a potential 10.7% upside. Kroger announced strategic growth initiatives including a $5 billion customer-value investment and plans to open 110 new stores by 2029. The com...

Analyst Insights
Bullish
1 hour ago
Crown Castle Q3 2026 earnings expected with mixed revenue decline but potential EPS growth.

Crown Castle Q3 2026 earnings expected with mixed revenue decline but potential EPS growth.

Crown Castle is set to report its Q3 2026 earnings with Wall Street expecting a 5.9% revenue decline to about $1.01 billion, mainly due to drops in site rental and services revenue. However, some forecasts predict a 7.1% rise in earnings per share to...

Company Fundamentals
Neutral
1 hour ago
PypeServer launches Cloud+ 3.0 to unify HVAC ductwork and piping fabrication in one platform.

PypeServer launches Cloud+ 3.0 to unify HVAC ductwork and piping fabrication in one platform.

PypeServer has released Cloud+ version 3.0, enabling HVAC contractors to manage both ductwork and piping fabrication on a single platform. This update allows seamless tracking from design through installation, integrating with existing design softwar...

Others
Bullish
1 hour ago
Kevel raises $52M to expand AI-driven commerce media infrastructure globally.

Kevel raises $52M to expand AI-driven commerce media infrastructure globally.

Kevel secured $52 million in its largest funding round to date, boosting its AI-powered infrastructure for commerce media networks. The capital will accelerate product innovation, transparent AI decisioning, and global expansion, helping retailers an...

Others
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App